Concepedia

Eliza Harting

EH

Statistics

Publications

3

Citations

689

H-Index

3

Active since

2018

Affiliations

Gilead Sciences (United States)(Current)

The University of Texas Health Science Center at San Antonio

University of California San Diego

Ruane Medical

Texas Liver Institute

Eliza Harting is an author at Gilead Sciences (United States) specializing in health sciences, medicine, and nonalcoholic fatty liver disease.

Top concepts

Publications per year

2018–2022

3

Publications

3

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

Rohit Loomba, Zeid Kayali, Mazen Noureddin et al. · Gastroenterology · 2018 · 329 citations · Full text

, , +12

Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel, Stephen A. Harrison, Magdy Elkhashab et al. · Hepatology · 2020 · 311 citations

Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

Eric Lawitz, Bal Raj Bhandari, Peter Ruane et al. · Clinical Gastroenterology and Hepatology · 2022 · 49 citations · Full text

1–3 of 3